Adding Ipilimumab to Nivolumab No Better in Pretreated Squamous NSCLC

FRIDAY, July 16, 2021 -- For patients with advanced, chemotherapy-pretreated, immune checkpoint inhibitor-naive squamous (Sq) non-small cell lung cancer (NSCLC), ipilimumab added to nivolumab does not improve outcomes versus nivolumab alone,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news